Tropical Disease Diagnostics Market Share & Forecast 2032

Market Insights

• Between 2024 and 2032, the global market for tropical disease diagnostics is projected to expand at a compound annual growth rate (CAGR) of 5.00%, from an estimated USD XX million in 2023 to USD XX million in 2032.
• The leading category is Malaria. The dengue category, on the other hand, is expected to grow at a strong CAGR.
• The molecular diagnostics category will expand rapidly.
• Throughout the projected period, the CAGR for diagnostic laboratories is anticipated to be the highest.
• Asia Pacific controlled the tropical disease diagnostics market.
• Regarding the market share of tropical disease diagnostics, Europe is expected to come second.
• North America is expected to experience the fastest growth in the tropical disease diagnostics industry.
• The global market for tropical disease diagnostics is expanding as a result of rising urbanization in tropical areas and rising rates of tropical disease transmission.
• Government financing and initiatives, along with advances in diagnostic technology, could benefit the tropical disease diagnostics industry.

Executive Summary

Market Definition

The creation, manufacturing, and distribution of diagnostic instruments and technologies intended especially to detect and treat diseases common in tropical and subtropical areas are all included in the tropical disease diagnostics market. These illnesses, which include diseases like Malaria, dengue fever, Chagas disease, leishmaniasis, and filariasis, among others, are usually brought on by pathogens, including bacteria, viruses, parasites, and fungi.

Market Overview

It is predicted that the tropical disease diagnostics industry will continue its upward trajectory between 2024 and 2032, growing at a compound annual growth rate (CAGR) of 5.00%. From its projected USD XX million in 2023 to USD XX million in 2032, the market will continue to grow.

The demand for diagnostics for tropical diseases is expanding due to rising awareness and screening initiatives. The need for diagnostic testing rises as a result of public health campaigns and educational programs that raise awareness of tropical diseases. People are more inclined to participate in screening programs when they are more aware, which facilitates early diagnosis and treatment. Particularly in high-risk communities, these programs-which are frequently funded by governmental and non-governmental organizations-focus on routine screening and community health education. As a result, there is a growing demand for trustworthy and easily available diagnostic instruments, which drives market growth and advancements in diagnostic technology.

The market for tropical disease diagnostics is expanding at a substantial rate due to improvements in the healthcare infrastructure. Accurate and quick disease diagnosis is made possible by improved facilities, hospitals with more modern equipment, and sophisticated laboratories. The use of advanced diagnostic technologies, which enhance disease identification and management, is supported by this infrastructural development, especially in tropical locations. Investments in healthcare systems, which are frequently supported by foreign and government funds, guarantee greater access to high-quality diagnostic services, which increases market demand and growth.

Segmentation by Type of Disease

• Malaria is the market leader in terms of disease type. The rising prevalence of Malaria, increased public health campaigns, technological developments in diagnostic equipment, and better healthcare infrastructure in endemic areas are the driving reasons for malaria diagnostics in the tropical disease diagnostics market. These elements promote the need for quick and precise malaria testing, which accelerates market expansion.
• The dengue category will exhibit a sizable CAGR during the projected period. In the tropical disease diagnostics market, dengue diagnostics is expected to grow due to a number of causes, including rising dengue epidemic frequency, government and international health organization initiatives, improvements in quick diagnostic tests, and greater public understanding and screening programs. All of these elements work together to raise demand for efficient dengue diagnostic products, which propels market growth.
• Other types of diseases, including chikungunya, zika virus, and parasitic infections, also support the need for tropical disease diagnostics.

Segmentation by Diagnostic Technology

• Molecular diagnostics are considered the best type of diagnostic technology. Because of their high sensitivity and specificity, quick detection speed, and technological breakthroughs like PCR and next-generation sequencing, molecular diagnostics are in high demand in the tropical disease diagnostics industry. Accurate diagnosis and efficient illness management depend on these instruments.
• The immunoassays category will likely register a significant CAGR during forecasting. Because immunoassays can detect antigens and antibodies quickly, cheaply, and accurately-which is essential for detecting diseases like dengue and Malaria in situations with limited resources-they are in high demand in the tropical disease diagnostics industry.
• Other diagnostic technologies, such as microscopy, rapid diagnostic tests (RDTs), and clinical laboratory tests, further enhance the need for tropical disease diagnostics.

Segmentation by End User

• The diagnostic laboratories category is projected to grow faster over the projection period. Diagnostic laboratories are in great demand in the tropical disease diagnostics industry because they assist disease surveillance and outbreak control and provide accurate, high-throughput testing capabilities. Improved laboratory facilities enable more accurate diagnosis of illnesses like dengue and Malaria.
• Other end users, including hospitals and clinics, research institutes, public health programs, and point-of-care settings, also influence the need for tropical disease diagnostics.

Segmentation by Region

• Asia Pacific leads the tropical disease diagnostics industry. This is due to the expanding demand for tropical disease diagnostics from the Asia Pacific countries such as China, India, Japan, and other countries.
• Europe is estimated to rank second in the market size of tropical disease diagnostics.
• It is anticipated that the tropical disease diagnostics market in North America will grow quickly.
• The remaining need for tropical disease diagnostics is met by regions including Latin America, the Middle East, and Africa.

The industry is expected to increase as a result of rising government initiatives and growing awareness of tropical diseases. For example, the United Nations Development Program's Sustainable Development Goals (SDG) include tropical diseases as a global target, which is expected to drive market growth. Additionally, throughout the projected period, a number of WHO efforts, like the Road Map 2030 for the Elimination of Tropical Diseases, are anticipated to propel market expansion.

It is anticipated that the tropical disease diagnostics market in Asia Pacific will surpass those in the entire world. This is because of several factors, including the significant burden of tropical diseases, rising healthcare costs, quick technical developments, proactive government activities, and growing public awareness of the use of PCR testing in the diagnosis of tropical diseases.

It is projected that the tropical disease diagnostics market will develop at the fastest rate in the North American region. This is because tropical diseases are more common in emerging nations in the region, and IVD product penetration has expanded. Furthermore, factors that are anticipated to propel market growth in North America include a rise in federal spending, the availability of qualified healthcare workers, and a growing emphasis by multinational diagnostic businesses on developing cutting-edge and innovative IVD products.

Key Highlights of the Report

The global tropical disease diagnostics market is segmented by type of disease, diagnostic technology, end user, and region. As far as the type of disease is concerned, Malaria is the market spearhead. Molecular diagnostics are the top diagnostic technology category. Throughout the forecast period, the category of diagnostic laboratories is expected to grow at the greatest CAGR. Asia Pacific is seeing the most growth in the tropical disease diagnostics market.

The expanding incidence of tropical diseases is one of the main factors driving the market's expansion overall during the projected timeframe. WHO estimates that every year, at least 1.7 billion people, or around one-fifth of the world's population, predominantly in developing and lower-income nations, need interventions for at least one tropical disease. Tropical diseases afflicted over 40% of the African continent. Poor people who live in tropical climates and hard-to-reach places are more likely to contract these diseases. The majority of tropical disease cases worldwide are caused by nations like China, Brazil, Yemen, India, Bangladesh, and several countries in Central and East Africa.

It is anticipated that the Asia Pacific will hold the biggest global market share for tropical disease diagnostics. The Asia Pacific market is growing as a result of escalating government spending on healthcare, rapid urbanization, and the incidence of tropical diseases. Other important factors are the development of technology and the expansion of the diagnostic infrastructure. In addition, it is projected that the market in North America will grow at the quickest rate. Increased instances associated with travel, a robust healthcare system, and improved diagnostic technology are the main drivers of growth. Notable trends include research funding and initiatives for managing tropical diseases.

Which Key Factors Are Driving The Global Tropical Disease Diagnostics Market?

The market for tropical disease diagnostics is being driven by the rise in point-of-care testing, expanded diagnostic laboratories, and improved public awareness and education.

What Are The Main Challenges Confronting The Global Tropical Disease Diagnostics Market?

The main obstacles confronting the tropical disease diagnostics sector are the lack of qualified medical and laboratory personnel, conflicting health priorities, and restricted access to cutting-edge diagnostic tools.

What Market Opportunities Exist For Tropical Disease Diagnostics Globally?

The development of quick diagnostic tests, enhanced disease surveillance systems, and cooperation between public and commercial sectors are some of the drivers supporting the tropical disease diagnostics market.

Market Drivers

Growing Frequency of Tropical Illnesses

The market for tropical disease diagnostics is expanding as a result of the rising incidence of tropical illnesses such as leishmaniasis, dengue, and Malaria. In tropical and subtropical countries, these diseases pose serious public health issues. Thus, there is an increased demand for timely and effective diagnostic techniques. Governments and healthcare systems place greater importance on early diagnosis and treatment in order to contain outbreaks and lower morbidity and mortality rates as the prevalence of these diseases rises. The ability to control and lower the effects of tropical illnesses on impacted people is improved by this increased demand, which spurs innovation and investment in revolutionary diagnostic tools.

Market Restraints

Lack of Awareness About Tropical Diseases and Their Symptoms

The market for tropical disease diagnostics is growing slowly due to a lack of knowledge about tropical diseases and associated symptoms. Diagnostic services are not being used to their full potential since many people in the afflicted areas are unaware of the symptoms or the significance of receiving a diagnosis as soon as possible. Inadequate understanding among healthcare personnel can sometimes lead to delayed or incorrect diagnoses. This ignorance restricts the market's potential and lowers the need for diagnostic testing. In order to improve diagnosis rates and support market growth, more education and awareness campaigns concerning tropical illnesses and their symptoms are needed.

Opportunities

Advancements in the Field of Diagnostic Technology

The market for tropical disease diagnostics has a lot of potential due to technological advancements in diagnosis. The precision and speed of pathogen identification have been enhanced by advanced molecular diagnostics like PCR and next-generation sequencing. Rapid diagnostic tests (RDTs) and enzyme-linked immunosorbent assays (ELISAs) are two examples of immunoassays that deliver simple, affordable methods of diagnosing tropical diseases like dengue and Malaria. The ability to diagnose diseases accurately and early because of technological breakthroughs is essential for managing and controlling illnesses. Furthermore, portable and point-of-care diagnostic tools increase accessibility in situations with limited resources and remote locations. By filling gaps in the market and enhancing healthcare results in tropical areas, ongoing innovation propels market expansion.

Competitive Landscape

Key Players

The highly competitive global market for tropical disease diagnostics is dominated by a number of significant players. A handful of the top market players are shown below, together with their respective market shares:

• F. Hoffmann-La Roche Ltd
• Abbott
• Thermo Fisher Scientific Inc.
• ZeptoMetrix
• InBios International, Inc.
• Genome Diagnostics Pvt. Ltd.
• Omega Diagnostics Group PLC
• Coris BioConcept
• DiaSys Diagnostic Systems GmbH
• Oscar Medicare Pvt Ltd.
• Others

In order to stay competitive, these organizations give priority to product innovation, expansion of their distribution channels, and mergers and acquisitions.

By creating cutting-edge ideas and goods, the foremost manufacturers in the global market for tropical disease diagnostics consistently strive to stay one step ahead of the competition.

In January 2023, Thermo Fisher Scientific Inc. (US) introduced its CE-IVD-certified TaqPath Seq HIV-1 Genotyping Kit.

In July 2022, Elecsys HCV Duo, an immunoassay developed by Roche, was introduced. It enables the concurrent and independent assessment of the hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample.

In January 2021, Novartis AG and the World Health Organization (WHO) partnered to give multidrug therapy (MDT) medications for the treatment of leprosy and to concentrate on implementing new leprosy treatment instruments.

In April 2020, Grifols announced the release of a new 3-mL vial for high-potency HyperRAB. This potency formulation of rabies immunoglobulin reduces the need for smaller vials for treatment of rabies postexposure prophylaxis and offers hospital pharmacists storage economies.

How are Companies Performing in the Tropical Disease Diagnostics Market?

Due to a number of significant factors, companies in the tropical disease diagnostics sector are performing well. To gain a larger market share, significant companies are launching a number of strategic projects. Collaborations, partnerships, and the development of new products are a few examples of these activities. A pledge to assist the Global Health Innovative Technology Fund, for example, was made by Astellas Pharma Inc. in May 2023. The fund focuses on the development of medications, diagnostics, and vaccines to help treat a variety of infectious diseases, including tropical diseases.

Due to the robust product portfolios and exceptional distribution networks of major companies in both developed and developing nations, the market for tropical disease diagnostics is semi-consolidated. In 2023, Abbott Laboratories, F. Hoffmann-La Roche AG, and Cepheid Inc. have a commanding proportion of the market. When paired with smart partnerships with the largest companies in the market, the introduction of diagnostic products should help enterprises expand and gain a larger portion of the market. But in the upcoming years, a number of domestic companies will be able to enter the market owing to the potential opportunities it offers. By 2030, the market will be somewhat fragmented as a result of this. In September 2021, for instance, the United Kingdom-based company LumiraDx announced that its merger with CA Healthcare Acquisition Corp. (CHAC) had been completed. LumiraDx was able to revolutionize diagnostic testing and broaden its range through the merger. The company now has a pipeline of more than thirty assays covering major health issues such as diabetes, coagulation disorders, infectious diseases, and cardiovascular diseases.

Renowned companies are prioritizing innovation and creating sophisticated diagnostic technologies that improve precision, speed, and user-friendliness. Companies like Abbott, Roche, and Thermo Fisher Scientific are making significant investments in R&D to develop molecular diagnostic tools, quick diagnostic kits, and point-of-care tests that are specific to tropical diseases like dengue, Malaria, and Zika.

Summary of Key Findings

• The market for tropical disease diagnostics is being supported by several factors, including the expansion of telemedicine services and the growing usage of mobile health (mHealth) technology.
• The market is segmented by type of disease, diagnostic technology, end user, and region.
• In the market, the most prevalent type of disease is Malaria.
• Molecular diagnostics are the foremost diagnostic technology category.
• The diagnostic laboratories category is expected to grow fastest in terms of CAGR during the forecast period.
• In terms of market development, Asia Pacific is a leader; the market is highly competitive with key players including F. Hoffmann-La Roche Ltd, Abbott, Thermo Fisher Scientific Inc., ZeptoMetrix, InBios International, Inc., Genome Diagnostics Pvt. Ltd., Omega Diagnostics Group PLC, Coris BioConcept, DiaSys Diagnostic Systems GmbH, Oscar Medicare Pvt Ltd., and Others.

Future Outlook

• The tropical disease diagnostics industry is expected to increase significantly in Asia Pacific, and its outlook is positive worldwide.
• The market will continue growing due to several factors, such as the expansion of personalized medicine and the use of automation in diagnostics.
• The main barriers to the growth of the tropical disease diagnostics sector are the low levels of funding and investment in research and development.
• Developing new products, reaching a wider market, and maintaining competitive prices are all necessary for major businesses to stay ahead of the competition.

How the Credence Research Tropical Disease Diagnostics Market Report Can Help CXOs

The Credence Research Tropical Disease Diagnostics Market Report provides CXOs with an extensive market overview and comprises the following:

• Market size and growth forecast: The study offers comprehensive market estimations for tropical disease diagnostics globally, broken down by type of disease, diagnostic technology, end user, and region. Furthermore, the report includes market forecasts through 2032, derived from key drivers and trends.
• Market segmentation: The tropical disease diagnostics market is divided into segments by type of disease, diagnostic technology, end user, and region in the research report. This segmentation helps CXOs understand the market and the opportunities inside each area in great depth.
• Competitive landscape: The study report provides a thorough analysis of the leading businesses in the tropical disease diagnostics sector, together with details on their revenue streams, product lines, and business strategies. With this information, CXOs can assess and identify their competitors.
• Key trends and drivers: The study report analyzes and highlights the key developments and elements driving the market for tropical disease diagnostics. CXOs can utilize this information to make well-informed choices regarding their plans and investments.

The Credence Research Tropical Disease Diagnostics Market Report provides CXOs with insights that they may utilize to:

• Identify growth opportunities: This analysis is likely to help CXOs find fresh growth prospects in the tropical disease diagnostics sector. For example, the research recognizes the increasing requirement for tropical disease diagnostics from hospitals and clinics as a crucial opportunity.
• Make informed investment decisions: The study aids CXOs in making informed decisions about tropical disease diagnostics. For example, it delivers information on the key variables to consider while picking solutions and evaluating suppliers.
• Develop competitive strategies: CXOs can utilize the research report to establish competitive strategies for their brain health supplement firms. The study paper explores the primary tactics employed by tropical disease diagnostics providers to set themselves apart from their rivals.
• Track market developments: By tracking market advancements, this research report could assist CXOs in remaining ahead of the curve. For example, it provides information about the latest advancements and patterns in the tropical disease diagnostics industry.

The Credence Research Tropical Disease Diagnostics Market Report is helpful for CXOs who want to learn more about the market and identify potential opportunities.

Segmentation

• By Type of Disease

  • Malaria
  • Dengue
  • Chikungunya
  • Zika Virus
  • Parasitic Infections

• By Diagnostic Technology

  • Molecular Diagnostics
  • Immunoassays
  • Microscopy
  • Rapid Diagnostic Tests (RDTs)
  • Clinical Laboratory Tests

• By End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Public Health Programs
  • Point-of-Care Settings

• By Region

  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • The Rest of the Middle East and Africa

Adjacent Markets

Several adjacent markets in the tropical disease diagnostics market have high revenue growth opportunities. The key adjacent markets for the tropical disease diagnostics market -